What Does Full Approval of Pfizer’s COVID-19 Vaccine Mean?

On Aug. 23, the FDA gave full approval to the Pfizer/BioNTech COVID-19 vaccine for people 16 and older. Since last December, nearly 202 million Americans have received at least one dose of a vaccine, including the two-dose vaccines made by Pfizer/BioNTech and Moderna, and Johnson & Johnson’s single-dose vaccine. In recent months, the pace of vaccinations has slowed even as the delta variant is causing a new wave of cases, hospitalizations and deaths. But the FDA’s endorsement of the Pfizer/BioNTech vaccine may convince more unvaccinated people to get their shot and clear the way for more employers to impose vaccine mandates. A recent poll from the Kaiser Family Foundation found that 31% of unvaccinated people would be more likely to get their shots if the vaccine gets full approval.

© 2024 MMIT
Jinghong Chen

Jinghong Chen Reporter

Jinghong produces infographics and data stories on health insurance and specialty pharmacy for AIS Health. She graduated from Missouri School of Journalism with a focus on data journalism and international reporting. Before joining AIS in 2018, she worked at WBEZ, Al Jazeera English and The New York Times Chinese.

Related Posts

iv-therapy
February 8

Incorporating Pharmacy Spending in Value-Based Payment Models Remains Challenging

READ MORE
pills-on-bills
February 8

As Reform Efforts Persisted, PBM Trade Association Set Its Lobbying Record in 2023

READ MORE
optum
February 8

Direct-to-Consumer Prescribing Could Have Downsides

READ MORE

GAIN THERAPEUTIC AREA-SPECIFIC INTEL TO DRIVE ACCESS FOR YOUR BRAND

Sign up for publications to get unmatched business intelligence delivered to your inbox.

subscribe today